CTVA

Corteva, Inc. 2026 Q2 10-Q Filing Summary

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2026, for Corteva, Inc. (CTVA) and its subsidiary EIDP, Inc. Corteva operates in two primary segments: Seed and Crop Protection. The company is currently preparing for a proposed separation of these two businesses into independent publicly traded companies, a transaction announced in October 2025. The filing includes unaudited consolidated financial statements and management discussion.

Key Financial Metrics (Six Months Ended June 30, 2026)

Note: Free Cash Flow is defined as Operating Cash Flow from continuing operations less Capital Expenditures. Operating Cash Flow was negative $3,345 million due to significant one-time outflows.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 4% year-over-year, driven by a 2% favorable currency impact, 1% volume growth, and 1% price increase. The Seed segment saw a 4% sales increase, while Crop Protection grew 3%.
• Profitability: While GAAP Net Income declined slightly due to significant charges, Operating EBITDA improved by 10% to $3.699 billion, reflecting successful cost and productivity actions and favorable pricing/mix.
• Cash Flow Volatility: Operating cash flow turned significantly negative (-$3.345 billion) compared to the prior year (-$1.139 billion). This was primarily driven by a $1.5 billion discretionary pension contribution, a $610 million settlement payment to Bayer, and a prepayment for FMC rimisoxafen.
• Debt Levels: Total debt increased to $4.875 billion, largely due to higher short-term borrowings used to fund working capital needs and the aforementioned large payments.

Guidance, Outlook, and Risks

• Proposed Separation: Management is actively preparing for the spin-off of Seed and Crop Protection businesses. Separation costs of $131 million were incurred in the first half of 2026.
• Restructuring: Two major restructuring programs are underway:
  • 2026 Restructuring Actions: Approved March 2026 to right-size the organization for the separation. Expected total charges of ~$80 million; $78 million recorded YTD.
  • Crop Protection Operations Strategy: Ongoing optimization including site closures (Pittsburg, CA; Asturias, Spain). Total expected charges range from $750 million to $815 million; $674 million recorded inception-to-date.
• Legal & Environmental Risks:
  • FTC Investigation: Settled with the FTC, State of Arkansas, and multi-district litigation plaintiffs regarding antitrust allegations. Accruals established for estimated resolution.
  • PFAS Litigation: Significant exposure related to legacy EIDP businesses. The company is subject to the MOU with Chemours and DuPont for cost-sharing. A NJ Statewide Settlement was reached (subject to court approval) involving aggregate payments of $875 million over 25 years.
  • Bayer Dispute: Resolved in Q1 2026 with a $610 million payment, terminating royalty obligations for Enlist E3 soybeans.
• Capital Allocation: The company returned ~$740 million to shareholders in the first half via dividends ($241 million) and share repurchases ($500 million). A $3 billion share buyback program remains active.

Investor Verification Checklist

• Cash Flow Sustainability: Verify the impact of the $1.5 billion pension contribution and $610 million Bayer payment on future liquidity and whether these are truly one-time events.
• Separation Timeline: Confirm the regulatory approval status and expected closing date for the proposed Seed/Crop Protection spin-off.
• Restructuring Completion: Monitor the progress of the Crop Protection Operations Strategy, specifically the closure of the Asturias, Spain site and associated costs.
• Legal Accruals: Review the sufficiency of accruals for the FTC settlement and ongoing PFAS litigation, particularly the NJ Statewide Settlement court approval status.
• Debt Covenants: Confirm continued compliance with the 0.60 total indebtedness to total capitalization ratio given the increase in short-term debt.